Scaling lentiviral vector manufacturing without tradeoffs: achieving higher purity and lower COGS through smarter bioprocessing

The scale-X bioreactor provides a biology-aligned alternative for scalable and cost effective production of LV, enabling decreased costs and patient accessibility. 

Watch the full showcase video to learn how to achieve:

• Maintained or 2–3x increased functional titers  
• 3x reduction in operational footprint  
• 3–20x lower contaminants in harvest  
• Up to 2–3x increased DSP recovery  
• Up to 4x less production batches  
• 25–65% COGs savings per dose

Click 'read now' below to view the video and showcase for free

Please enter your email to access content Read now